DocuSign Reports Q1 Revenue of $830.24M, Beats Estimates
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Source: NASDAQ.COM
- Significant Revenue Growth: DocuSign reported $830.24 million in revenue for the quarter ended April 2026, reflecting an 8.7% year-over-year increase, which surpasses market expectations and indicates sustained growth potential in the e-signature market.
- Earnings Per Share Beat: The EPS for the quarter was $1.09, up 21.1% from $0.90 a year ago, and exceeded analyst expectations of $1.00, showcasing an enhancement in the company's profitability.
- Positive Market Reaction: With both revenue and EPS exceeding Wall Street forecasts, investor sentiment towards DocuSign is optimistic, potentially driving stock price increases and bolstering market confidence.
- Key Metrics Analysis: Analysts emphasize that while revenue and earnings are focal points, the performance of other key metrics provides deeper insights into the company's operations, aiding investors in better predicting stock price movements.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DOCU?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DOCU
Wall Street analysts forecast DOCU stock price to rise
16 Analyst Rating
3 Buy
13 Hold
0 Sell
Hold
Current: 50.940
Low
70.00
Averages
80.23
High
105.00
Current: 50.940
Low
70.00
Averages
80.23
High
105.00
About DOCU
DocuSign, Inc. provides intelligent agreement management (IAM) platform an eSignature solution, and contract lifecycle management (CLM) solution - allow organizations to increase productivity, accelerate contract review cycles, and transform agreement data into insights and actions. The Company’s IAM platform automates agreement workflows, uncovers actionable insights, and leverages artificial intelligence (AI) capabilities, enabling organizations to create, commit, and manage agreements virtually. Its products include eSignature, CLM, IAM Apps, and Add-on Products. Its Add-on Products include Payments to collect payments along with signed agreements; Identity and standards-based signature for enhanced signer-identification and signatures with digital certification; Notary for remote online notarization; Monitor for advanced analytics; Gen for Salesforce for automated agreement generation within Salesforce, among others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
DocuSign Reports Q1 Revenue of $830.24M, Beats Estimates
- Significant Revenue Growth: DocuSign reported $830.24 million in revenue for the quarter ended April 2026, reflecting an 8.7% year-over-year increase, which surpasses market expectations and indicates sustained growth potential in the e-signature market.
- Earnings Per Share Beat: The EPS for the quarter was $1.09, up 21.1% from $0.90 a year ago, and exceeded analyst expectations of $1.00, showcasing an enhancement in the company's profitability.
- Positive Market Reaction: With both revenue and EPS exceeding Wall Street forecasts, investor sentiment towards DocuSign is optimistic, potentially driving stock price increases and bolstering market confidence.
- Key Metrics Analysis: Analysts emphasize that while revenue and earnings are focal points, the performance of other key metrics provides deeper insights into the company's operations, aiding investors in better predicting stock price movements.
See More
US Stocks Plunge Sharply, Tech Sector Under Pressure
- Market Decline: The S&P 500 fell 2.64% and the Nasdaq 100 dropped 4.77%, indicating a significant loss of investor confidence in tech stocks, particularly as AI infrastructure and semiconductor companies faced sell-offs, which could impact future investment strategies.
- Strong Employment Data: US nonfarm payrolls rose by 172,000 in May, significantly exceeding expectations of 88,000, while the unemployment rate held steady at 4.3%, potentially prompting the Fed to consider a rate hike at the upcoming meeting, thereby affecting market liquidity and investor sentiment.
- Rising Bond Yields: The 10-year Treasury yield climbed to 4.55%, a two-week high, reflecting heightened expectations for future rate hikes, which may lead to capital outflows from the stock market, further exacerbating market volatility.
- Tech Stock Retreat: Following Broadcom's disappointing chip sales outlook, Marvell and Micron stocks plummeted over 16% and 13%, respectively, suggesting that the market's overly optimistic sentiment towards tech stocks may be correcting, impacting investor confidence.
See More
US Stock Markets Plunge as Tech Stocks Retreat
- Market Weakness: The S&P 500 index fell by 1.00% and the Nasdaq 100 dropped by 2.08%, both reaching two-week lows, indicating a significant investor rotation out of AI infrastructure and semiconductor stocks, which could impact future investment strategies.
- Strong Employment Data: US nonfarm payrolls rose by 172,000 in May, significantly exceeding expectations of 88,000, with April's figures revised up to 179,000, demonstrating economic resilience that may prompt the Fed to consider a rate hike in the upcoming meeting.
- Rising Bond Yields: The 10-year Treasury note yield reached a two-week high of 4.54%, reflecting heightened market expectations for a Fed interest rate increase, which may lead investors to reassess risks in the stock market.
- International Market Declines: European and Asian stock markets are generally lower, with China's Shanghai Composite falling to a seven-week low, indicating that global economic uncertainties could have a ripple effect on the US market.
See More
Quantum Stocks Decline While Consumer Staples Rise
- Quantum Stocks Struggle: Quantinuum's debut on Nasdaq was lackluster, closing flat and subsequently dropping over 8% on Friday, falling below its IPO price of $60 per share, indicating market caution towards the quantum computing sector which may impact future funding and investor confidence.
- Consumer Staples Surge: Amid Friday's market sell-off, the consumer staples sector rose 2%, with companies like Colgate-Palmolive, Coca-Cola, and Procter & Gamble gaining over 3%, reflecting investor preference for defensive stocks, which could lead to a shift in capital towards these stable industries.
- Strong Performance in Medical Devices: Cooper Companies reported second-quarter adjusted earnings of $1.21 per share, exceeding the $1.10 consensus estimate, with revenue of $1.08 billion surpassing the $1.05 billion forecast, showcasing robust performance in the medical device sector that may attract more investor interest.
- Software Stocks Outlook Weakens: Docusign's outlook failed to impress, with shares slipping 6% as it projected second-quarter revenue between $865 million and $869 million, slightly below consensus, potentially affecting its future market performance and investor confidence.
See More
US Stocks Decline as Tech Sector Pulls Back
- US Stock Index Decline: The S&P 500 index fell by 0.90%, the Dow Jones Industrial Average dropped by 0.32%, and the Nasdaq 100 decreased by 1.85%, indicating investor rotation away from AI infrastructure and semiconductor stocks, which pressured the market and pushed it to a 1.5-week low.
- Employment Data Impact: US May nonfarm payrolls rose by 172,000, exceeding expectations of 88,000, while April's figures were revised up to 179,000, leading the 10-year T-note yield to rise to a two-week high of 4.54%, intensifying speculation about a Fed rate hike.
- Tech Sector Pullback: Following Broadcom's disappointing chip sales outlook, chipmakers and AI infrastructure stocks retreated for a second day, with ON Semiconductor and ARM Holdings both down over 8%, reflecting concerns over excessive optimism in the AI trade.
- International Market Weakness: Overseas stock markets were generally lower, with the Euro Stoxx 50 down 0.17% and China's Shanghai Composite falling to a seven-week low, highlighting the impact of global economic uncertainty on market sentiment.
See More
Mid-Cap Stock Investment Opportunities Analysis
- DocuSign's Weak Performance: DocuSign (DOCU), with a market cap of $9.9 billion, has shown disappointing average ARR growth of only 8.8% over the past year, indicating challenges in securing long-term deals and renewals, which complicates justifying sales and marketing investments that could enhance revenue growth potential.
- Globus Medical's Strong Growth: Globus Medical (GMED), valued at $10.86 billion, has achieved an impressive annual revenue growth of 30.3% over the past five years, demonstrating resilience in various global economic conditions, while its earnings per share have increased by 22.2% annually, showcasing its strong competitive position in the spine and neurosurgery markets.
- RB Global's Outstanding Market Performance: RB Global (RBA), with a market cap of $19.66 billion, has recorded an annual revenue growth of 26.9% over the past five years, with an adjusted operating margin expansion of 2.5 percentage points, reflecting its scaling efficiency, and its earnings per share have grown by 19.1% annually, significantly outpacing its peers.
- Mid-Cap Investment Outlook: Despite facing competition from larger firms, mid-cap stocks present unique investment opportunities, and StockStory aids investors in identifying companies with solid fundamentals, enabling them to capitalize on market opportunities, particularly in the current economic landscape.
See More
DocuSign Reports Q1 Revenue of $830.24M, Beats Estimates
- Significant Revenue Growth: DocuSign reported $830.24 million in revenue for the quarter ended April 2026, reflecting an 8.7% year-over-year increase, which surpasses market expectations and indicates sustained growth potential in the e-signature market.
- Earnings Per Share Beat: The EPS for the quarter was $1.09, up 21.1% from $0.90 a year ago, and exceeded analyst expectations of $1.00, showcasing an enhancement in the company's profitability.
- Positive Market Reaction: With both revenue and EPS exceeding Wall Street forecasts, investor sentiment towards DocuSign is optimistic, potentially driving stock price increases and bolstering market confidence.
- Key Metrics Analysis: Analysts emphasize that while revenue and earnings are focal points, the performance of other key metrics provides deeper insights into the company's operations, aiding investors in better predicting stock price movements.
See More
US Stocks Plunge Sharply, Tech Sector Under Pressure
- Market Decline: The S&P 500 fell 2.64% and the Nasdaq 100 dropped 4.77%, indicating a significant loss of investor confidence in tech stocks, particularly as AI infrastructure and semiconductor companies faced sell-offs, which could impact future investment strategies.
- Strong Employment Data: US nonfarm payrolls rose by 172,000 in May, significantly exceeding expectations of 88,000, while the unemployment rate held steady at 4.3%, potentially prompting the Fed to consider a rate hike at the upcoming meeting, thereby affecting market liquidity and investor sentiment.
- Rising Bond Yields: The 10-year Treasury yield climbed to 4.55%, a two-week high, reflecting heightened expectations for future rate hikes, which may lead to capital outflows from the stock market, further exacerbating market volatility.
- Tech Stock Retreat: Following Broadcom's disappointing chip sales outlook, Marvell and Micron stocks plummeted over 16% and 13%, respectively, suggesting that the market's overly optimistic sentiment towards tech stocks may be correcting, impacting investor confidence.
See More
US Stock Markets Plunge as Tech Stocks Retreat
- Market Weakness: The S&P 500 index fell by 1.00% and the Nasdaq 100 dropped by 2.08%, both reaching two-week lows, indicating a significant investor rotation out of AI infrastructure and semiconductor stocks, which could impact future investment strategies.
- Strong Employment Data: US nonfarm payrolls rose by 172,000 in May, significantly exceeding expectations of 88,000, with April's figures revised up to 179,000, demonstrating economic resilience that may prompt the Fed to consider a rate hike in the upcoming meeting.
- Rising Bond Yields: The 10-year Treasury note yield reached a two-week high of 4.54%, reflecting heightened market expectations for a Fed interest rate increase, which may lead investors to reassess risks in the stock market.
- International Market Declines: European and Asian stock markets are generally lower, with China's Shanghai Composite falling to a seven-week low, indicating that global economic uncertainties could have a ripple effect on the US market.
See More
Quantum Stocks Decline While Consumer Staples Rise
- Quantum Stocks Struggle: Quantinuum's debut on Nasdaq was lackluster, closing flat and subsequently dropping over 8% on Friday, falling below its IPO price of $60 per share, indicating market caution towards the quantum computing sector which may impact future funding and investor confidence.
- Consumer Staples Surge: Amid Friday's market sell-off, the consumer staples sector rose 2%, with companies like Colgate-Palmolive, Coca-Cola, and Procter & Gamble gaining over 3%, reflecting investor preference for defensive stocks, which could lead to a shift in capital towards these stable industries.
- Strong Performance in Medical Devices: Cooper Companies reported second-quarter adjusted earnings of $1.21 per share, exceeding the $1.10 consensus estimate, with revenue of $1.08 billion surpassing the $1.05 billion forecast, showcasing robust performance in the medical device sector that may attract more investor interest.
- Software Stocks Outlook Weakens: Docusign's outlook failed to impress, with shares slipping 6% as it projected second-quarter revenue between $865 million and $869 million, slightly below consensus, potentially affecting its future market performance and investor confidence.
See More
US Stocks Decline as Tech Sector Pulls Back
- US Stock Index Decline: The S&P 500 index fell by 0.90%, the Dow Jones Industrial Average dropped by 0.32%, and the Nasdaq 100 decreased by 1.85%, indicating investor rotation away from AI infrastructure and semiconductor stocks, which pressured the market and pushed it to a 1.5-week low.
- Employment Data Impact: US May nonfarm payrolls rose by 172,000, exceeding expectations of 88,000, while April's figures were revised up to 179,000, leading the 10-year T-note yield to rise to a two-week high of 4.54%, intensifying speculation about a Fed rate hike.
- Tech Sector Pullback: Following Broadcom's disappointing chip sales outlook, chipmakers and AI infrastructure stocks retreated for a second day, with ON Semiconductor and ARM Holdings both down over 8%, reflecting concerns over excessive optimism in the AI trade.
- International Market Weakness: Overseas stock markets were generally lower, with the Euro Stoxx 50 down 0.17% and China's Shanghai Composite falling to a seven-week low, highlighting the impact of global economic uncertainty on market sentiment.
See More
Mid-Cap Stock Investment Opportunities Analysis
- DocuSign's Weak Performance: DocuSign (DOCU), with a market cap of $9.9 billion, has shown disappointing average ARR growth of only 8.8% over the past year, indicating challenges in securing long-term deals and renewals, which complicates justifying sales and marketing investments that could enhance revenue growth potential.
- Globus Medical's Strong Growth: Globus Medical (GMED), valued at $10.86 billion, has achieved an impressive annual revenue growth of 30.3% over the past five years, demonstrating resilience in various global economic conditions, while its earnings per share have increased by 22.2% annually, showcasing its strong competitive position in the spine and neurosurgery markets.
- RB Global's Outstanding Market Performance: RB Global (RBA), with a market cap of $19.66 billion, has recorded an annual revenue growth of 26.9% over the past five years, with an adjusted operating margin expansion of 2.5 percentage points, reflecting its scaling efficiency, and its earnings per share have grown by 19.1% annually, significantly outpacing its peers.
- Mid-Cap Investment Outlook: Despite facing competition from larger firms, mid-cap stocks present unique investment opportunities, and StockStory aids investors in identifying companies with solid fundamentals, enabling them to capitalize on market opportunities, particularly in the current economic landscape.
See More
